BRIEF-Puma Biotechnology's marketing authorization application for neratinib validated by EMA
August 22, 2016 at 16:50 PM EDT
* Marketing authorization application for neratinib has been validated by European Medicines Agency Source text (http://bit.ly/2bxvgWa) Further company coverage:
